Yvoire Classic Plus

Details

YVOIRE Classic Plus is a cross-linked hyaluronic acid dermal filler with lidocaine, developed for controlled correction of facial wrinkles and folds in routine aesthetic practice. The product is supplied in a 1.0 mL syringe and is intended for injection into the mid dermal layer. Its formulation supports predictable tissue integration while maintaining a natural appearance after treatment. 

YVOIRE Classic Plus is commonly selected for moderate correction where precision and consistency are required. The product is positioned for use by trained professionals as part of structured facial injection protocols.

Product concept and clinical application

YVOIRE Classic Plus is manufactured using proprietary HICE cross-linking technology, which is designed to optimize the balance between elasticity and structural stability of hyaluronic acid. This technology allows efficient cross-linking while limiting unnecessary modification of the HA chains, supporting high purity of the final filler material. 

The product is intended for dermal injection to address wrinkles and facial folds, where controlled distribution and even integration into the tissue are essential. Clinical trial data provided by the manufacturer demonstrate a stable correction effect over time, supporting consistent treatment outcomes rather than transient volume changes. Lidocaine at a concentration of 0.3% is included to improve comfort during injection, without altering the mechanical behavior or clinical performance of the filler.

Key characteristics of YVOIRE Classic Plus

• Cross-linked hyaluronic acid filler produced with HICE technology to support elasticity and structural control
• High purity hyaluronic acid formulation, designed to reduce unnecessary residual cross-linking agents
• Intended for mid-dermal injection for wrinkle and fold correction
• Supplied in a 1.0 mL syringe with lidocaine to support patient comfort during treatment
• Compatible with standard aesthetic injection techniques using appropriate needle